BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 89 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $176,069 | +72356.4% | 61,348 | +45343.0% | 0.00% | – |
| Q4 2022 | $243 | -75.7% | 135 | -76.4% | 0.00% | – |
| Q3 2022 | $1,000 | -66.7% | 573 | -45.6% | 0.00% | – |
| Q2 2022 | $3,000 | -40.0% | 1,054 | -46.3% | 0.00% | – |
| Q1 2022 | $5,000 | -86.5% | 1,962 | -71.5% | 0.00% | – |
| Q4 2021 | $37,000 | -91.1% | 6,896 | -85.9% | 0.00% | – |
| Q3 2021 | $414,000 | -39.6% | 48,898 | -13.0% | 0.00% | – |
| Q2 2021 | $685,000 | -77.9% | 56,200 | -56.1% | 0.00% | -100.0% |
| Q1 2021 | $3,103,000 | +1198.3% | 127,891 | +1612.1% | 0.00% | – |
| Q4 2020 | $239,000 | +177.9% | 7,470 | +161.6% | 0.00% | – |
| Q3 2020 | $86,000 | -49.1% | 2,856 | -28.4% | 0.00% | – |
| Q2 2020 | $169,000 | +92.0% | 3,989 | +12.8% | 0.00% | – |
| Q1 2020 | $88,000 | – | 3,537 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $110,568,000 | 2.92% |
| Boxer Capital, LLC | 2,014,858 | $64,576,000 | 2.08% |
| RA Capital Management | 2,589,904 | $83,006,000 | 1.16% |
| Artal Group S.A. | 1,646,517 | $52,771,000 | 1.13% |
| Burrage Capital Management LLC | 34,891 | $1,118,000 | 0.85% |
| Bellevue Group AG | 1,403,000 | $44,967,000 | 0.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $25,720,000 | 0.51% |
| Ikarian Capital, LLC | 293,941 | $9,421,000 | 0.42% |
| Avoro Capital Advisors LLC | 640,000 | $20,512,000 | 0.35% |
| Logos Global Management LP | 123,465 | $3,957,000 | 0.34% |